ReviewClinics in laboratory medicine2018
Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge.
Review in Clinics in laboratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Consumption of fast foods and ultra-processed foods and breast cancer risk: a systematic review and meta-analysis.Global health research and policy · 2025Pooled it
- Contraceptive use with breast cancer incidence in Indonesia.Breast disease · 2024Pooled it
- Pooled it
- Review
- Low-Cost Dual-Dye Axillary Reverse Mapping in Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy: A Phase I Feasibility and Arm-Related Quality of Life Outcomes Study.World journal of surgery · 2026Article
- CDC42SE1 as a novel prognostic biomarker with immunomodulatory associations in breast invasive carcinoma.Discover oncology · 2026Article
- Clinical features, diagnosis, and referral of women with breast abnormalities in primary health care settings in rural Ethiopia: a retrospective record analysis.BMC primary care · 2026Article
- Screening for distress among metastatic breast cancer patients at a tertiary cancer center in Southwest Nigeria: Using the NCCN distress thermometer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Article
- Shared decision-making in Cervical Cancer Care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A mixed-methods study.PloS one · 2026Article
- Breast Health Training Program for Traditional Healers: A Pathway to Early Breast Cancer Detection in Tanzania.Cancer reports (Hoboken, N.J.) · 2026Article
- Factors Influencing Time to Treatment Initiation for Breast Cancer in Ethiopia.Cancer medicine · 2025Article
- Insights into Cancer Patients' Experiences and Needs in the Northeast Region of India: A Qualitative Study.Healthcare (Basel, Switzerland) · 2025Article
- ESPWA: a deep learning-enabled tool for precision-based use of endocrine therapy in resource-limited settings.bioRxiv : the preprint server for biology · 2025Article
- Breast cancer is detectable from peripheral blood using machine learning over T cell receptor repertoires.NPJ systems biology and applications · 2025Article
- Persistence to Adjuvant Endocrine Therapy for Breast Cancer in Botswana: An Observational Cohort Analysis.Breast care (Basel, Switzerland) · 2025Article
- Knowledge to action: a pilot quality improvement intervention on breast cancer specimen handling in operating rooms in Southern Ethiopia.The oncologist · 2025Article
- Barriers and contributions of rural community health workers in enabling cancer early detection and subsequent care in India: a qualitative study.BMC public health · 2025Article
- Female healthcare undergraduates' scientific readiness for raising breast cancer awareness in Syrian conservative community.BMC medical education · 2025Article
- A review of papillary breast carcinoma in women attending a breast imaging centre in Johannesburg.SA journal of radiology · 2025Article
5 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Breast cancer is the leading cause of cancer mortality among women in developing countries. Timely and accurate histopathological diagnosis of breast cancer is critical to delivering high-quality breast cancer care to patients in low- and middle-income countries (LMIC). The most important prognostic factors in breast cancer along with tumor size and nodal status are tumor grade, estrogen receptor status, as well as HER2 status in countries where specific targeted therapies are available. In addition, detailed and complete cancer registry data are needed to assess a country's disease burden and guide disease prioritization and allocation of resources for breast cancer treatment. Innovations in leapfrog technology and low-cost point-of-care tests for molecular evaluations are needed to provide accurate and timely pathology, with the ultimate goal of improving survival outcomes for patients with breast cancer in LMIC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.